1234931005: Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorised by structure\Metal and/or metallic compound-containing product\Aluminium and/or aluminium compound-containing product\Aluminium hydroxide-containing product\Aluminium hydroxide-containing product in oral dose form\Aluminium hydroxide- and magnesium hydroxide-containing product in oral dose form\Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form\Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form\Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension
\Medicinal product categorised by structure\Metal and/or metallic compound-containing product\Aluminium and/or aluminium compound-containing product\Aluminium hydroxide-containing product\Aluminium hydroxide- and magnesium hydroxide-containing product\Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product\Aluminium hydroxide and magnesium hydroxide and oxetacaine only product\Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form\Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension
\Medicinal product categorised by structure\Metal and/or metallic compound-containing product\Aluminium and/or aluminium compound-containing product\Aluminium hydroxide-containing product\Aluminium hydroxide- and magnesium hydroxide-containing product\Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product\Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form\Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form\Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension
\Medicinal product categorised by structure\Metal and/or metallic compound-containing product\Aluminium and/or aluminium compound-containing product\Aluminium hydroxide-containing product\Aluminium hydroxide- and magnesium hydroxide-containing product\Aluminium hydroxide- and magnesium hydroxide-containing product in oral dose form\Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form\Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form\Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension
\Medicinal product categorised by structure\Metal and/or metallic compound-containing product\Magnesium and/or magnesium compound-containing product\Magnesium hydroxide-containing product\Magnesium hydroxide-containing product in oral dose form\Aluminium hydroxide- and magnesium hydroxide-containing product in oral dose form\Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form\Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form\Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension
\Medicinal product categorised by structure\Metal and/or metallic compound-containing product\Magnesium and/or magnesium compound-containing product\Magnesium hydroxide-containing product\Aluminium hydroxide- and magnesium hydroxide-containing product\Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product\Aluminium hydroxide and magnesium hydroxide and oxetacaine only product\Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form\Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension
\Medicinal product categorised by structure\Metal and/or metallic compound-containing product\Magnesium and/or magnesium compound-containing product\Magnesium hydroxide-containing product\Aluminium hydroxide- and magnesium hydroxide-containing product\Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product\Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form\Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form\Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension
\Medicinal product categorised by structure\Metal and/or metallic compound-containing product\Magnesium and/or magnesium compound-containing product\Magnesium hydroxide-containing product\Aluminium hydroxide- and magnesium hydroxide-containing product\Aluminium hydroxide- and magnesium hydroxide-containing product in oral dose form\Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form\Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form\Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Oxetacaine-containing product\Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product\Aluminium hydroxide and magnesium hydroxide and oxetacaine only product\Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form\Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension
\Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Oxetacaine-containing product\Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product\Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form\Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form\Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension

\Medicinal product categorised by therapeutic role\Laxative agent\Magnesium hydroxide-containing product in oral dose form\Aluminium hydroxide- and magnesium hydroxide-containing product in oral dose form\Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form\Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form\Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension

\Product manufactured as oral dose form\Magnesium hydroxide-containing product in oral dose form\Aluminium hydroxide- and magnesium hydroxide-containing product in oral dose form\Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form\Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form\Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension
\Product manufactured as oral dose form\Aluminium hydroxide-containing product in oral dose form\Aluminium hydroxide- and magnesium hydroxide-containing product in oral dose form\Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form\Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form\Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension

Status: current, Defined. Date: 31-Jul 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

5084760010 Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension en Synonym Active Initial character case insensitive SNOMED CT core

5084761014 Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core

5084762019 Aluminum hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxethazaine 2 mg/mL oral suspension en Synonym Active Initial character case insensitive SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	Has manufactured dose form	Oral suspension	true	Inferred relationship	Some
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	Plays role	Laxative therapeutic role	true	Inferred relationship	Some
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	Has precise active ingredient	Oxethazaine	true	Inferred relationship	Some	1
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	Has BoSS	Oxethazaine	true	Inferred relationship	Some	1
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	1
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	1
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	Has precise active ingredient	Aluminium hydroxide	true	Inferred relationship	Some	2
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	Has BoSS	Aluminium hydroxide	true	Inferred relationship	Some	2
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	2
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	2
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	Has precise active ingredient	Magnesium hydroxide	true	Inferred relationship	Some	3
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	Has BoSS	Magnesium hydroxide	true	Inferred relationship	Some	3
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	3
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	3
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	Is a	Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form	true	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
5084760010	Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension	en	Synonym	Active	Initial character case insensitive	SNOMED CT core
5084761014	Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
5084762019	Aluminum hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxethazaine 2 mg/mL oral suspension	en	Synonym	Active	Initial character case insensitive	SNOMED CT core